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SINGH V. PGA TOUR: A DAVID V. GOLIATH BATTLE
“If Vijay Singh’s lawsuit against the PGA Tour were a golfer,
it would be officially on the clock.”1
I. INTRODUCTION
Vijay Singh (“Vijay”) is known as one of the hardest working
golfers on the Professional Golfers Association Tour (“the Tour”).2
His tireless work ethic resulted in three major titles including the
2000 Masters, and two PGA Championships in 1998 and 2004.3
Furthermore, Vijay holds the record for most wins after the age of
forty and, in 2004, was ranked the number one golfer in the world,
which he remained for a total of thirty-two weeks.4  Vijay’s diligence
on the practice range has translated into consistency throughout
his career and ranked him third all-time on the list of career money
winners.5
However, a January 2013 Sports Illustrated article caused
Vijay’s hard-working reputation to encounter skepticism for the
first time.6  In the article, Vijay admitted using a product called
deer antler spray, but said he did not know it contained a banned
1. Pete Madden, Vijay Singh’s Lawsuit Against PGA Tour Over Deer Antler Spray
Moves Slowly, GOLF MAGAZINE (June 3, 2014, updated Dec. 1, 2014), http://www
.golf.com/tour-and-news/vijay-singh’s-lawsuit-against-pga-tour-over-deer-antler-
spray-moves-slowly (describing slow pace of Vijay’s lawsuit).
2. See Derek Lawrenson, Golf Legend Vijay Fortified by Hard Work Not Lure of
Cash- Even at 45, DAILY MAIL (Jan. 7, 2009, 18:37 EST), http://www.dailymail.co
.uk/sport/golf/article-1100475/Vijay-Singh-fortified-hard-work-lure-cash—age-45
.html (noting Vijay’s famous work ethic).
3. See Bio, THE OFFICIAL WEBSITE OF VIJAY SINGH, http://www.vijaysinghgolf
.com/biography (last visited Mar. 8, 2016) (detailing Vijay’s career major
victories).
4. See id. (describing Vijay’s record number of wins after age forty).
5. See Stats – Career Money Leaders, PGA TOUR, http://www.pgatour.com/stats/
stat.110.html (last visited Oct. 10, 2015) (listing career money leaders on Tour).
6. See David Epstein, Snake Oil For Sale and the Athletes Who, Science Be Damned,
Think it Might Work, SPORTS ILLUSTRATED, Feb. 4, 2013, available at http://www.si
.com/vault/2013/02/04/106280221/snake-oil-for-sale-and-the-athletes-who-sci
ence-be-damned-think-it-might-work; see also Douglas Han, What Do Vijay Singh and
Barry Bonds Have in Common?, THE TEE SHEET (Feb. 4, 2013), http://www
.theteesheet.com/teeing-off/singh-bonds-full/ (drawing similarities between Vijay
and Barry Bonds, casting doubt on Vijay’s hardworking reputation).  The article
was initially posted to the Sports Illustrated website on January 29, 2013 under a
different title. See The Zany Story of Two Self Ordained Sports Science Entrepreneurs,
Sports Illustrated (Jan. 28, 2013), http://www.si.com/nfl/2013/01/28/strange-
lab-lured-numerous-athletes.
(337)
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performance enhancer.7  As a result, the Tour began an investiga-
tion that spanned three months.8  Finally, on April 30, 2013, the
Tour Commissioner, Tim Finchem, announced that Vijay would
not face punishment.9  Ironically, just one week later on the eve of
the 2013 Players Championship, the Tour’s flagship tournament,
Vijay filed a lawsuit against the Tour for its management of the
investigation.10
This comment analyzes the Tour’s duty of good faith and fair
dealing with players, the Tour’s alleged conversion of Vijay’s prize
money, and the Tour’s Anti-Doping Program by focusing on Singh
v. PGA Tour.  First, Section II (A) highlights the history of the Anti-
Doping Program on the Tour.11  Next, Section II (B)(C) discusses
Vijay’s particular situation by reviewing the events preceding his
lawsuit.12  Section II (D) discusses the progression of Vijay’s law-
suit.13  Section III (A)(C) reviews the implied covenant of good
faith and fair dealing for contracts as well as conversion under New
York law.14  Section III (D)(E) predicts the possible outcomes of
both claims in court and the potential arguments by both sides.15
Section IV concludes with a note on the possibly monumental im-
plications of Vijay’s lawsuit.16
7. See Steve DiMeglio, Vijay Singh Files Suit Against PGA Tour, USA TODAY (May
8, 2013, 9:00 PM), http://www.usatoday.com/story/sports/golf/2013/05/08/
vijay-singh-pga-tour-deer-antler-spray/2143849/ (reporting Vijay’s lawsuit against
Tour).
8. See Doug Ferguson, Tour Drops Its Doping Case Against Vijay Singh, YAHOO!
NEWS (APR. 30, 2013, 5:56 PM), http://news.yahoo.com/tour-drops-doping-case-
against-vijay-singh-203335757.html (detailing events leading up to lawsuit).
9. See Adam Fonseca, PGA Tour Commissioner Tim Finchem Says ‘No Sanctions for
Vijay Singh,’ SB NATION (Apr. 30, 2013, 3:59 PM), http://www.sbnation.com/golf/
2013/4/30/4287004/vijay-singh-deer-antler-spray-peds-pga-tour-ruling (reporting
Finchem’s announcement that Vijay would not be punished).
10. See DiMeglio, supra note 7 (reporting Vijay’s lawsuit).
11. See infra notes 17–60 and accompanying text (summarizing brief history of
Tour’s Anti-Doping Program).
12. See infra notes 61–88 and accompanying text (detailing circumstances
prior to lawsuit).
13. See infra notes 89–135 and accompanying text (describing progression of
lawsuit).
14. See infra notes 136–66 and accompanying text (analyzing covenant of
good faith and fair dealing and conversion including possible damages).
15. See infra notes 167–212 and accompanying text (predicting possible out-
come of both claims).
16. See infra notes 213–24 and accompanying text (concluding by noting pos-
sible far-reaching implications of trial).
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II. BACKGROUND
A. History of the Tour’s Anti-Doping Program
The Professional Golfers Association of America (“PGA”) offi-
cially began in 1916.17  Its humble beginnings included mostly club
professionals who taught lessons and managed country clubs.18
However, by the 1960’s the organization included many touring
professionals whose livelihood was playing tournament golf for
money.19  As a result, in 1968 the touring professionals split from
the PGA of America to form the PGA Tour.20
As many other professional sporting leagues continued to grow
in popularity, most adopted drug-testing policies in response to re-
cent scandals.21  However, the Tour did not adopt a drug-testing
policy because of its unique position among the professional
sports.22  Golf is physically distinct because it does not involve any
contact, and it is ethically distinguishable from other sports because
players call their own penalties.23
Nevertheless, in 2008 the “Tour reluctantly joined the modern
era of sports” by implementing the Anti-Doping Program.24  The
random drug testing policy affects all tournaments conducted by
the Tour and includes around five hundred tests per season.25  This
important change for the Tour created expectations of enhanced
17. See PGA of America History – 1916-1919, PGA, http://www.pga.com/pga-
america/pga-feature/pga-america-history-1916-1919 (last visited Mar. 8, 2016)
(chronicling early history of PGA).
18. See PGA of America History – 1960-1969, PGA, http://www.pga.com/pga-
america/pga-feature/pga-america-history-1960-1969 (summarizing history of PGA
of America from 1960-1969); see generally Stan Awtrey, Professionals’ Split was a Good
Thing for the Game, PGATOUR.com (Feb. 11, 2009), http://www.pgatour.com/
news/2009/02/11/awtrey_column.print.html (providing additional details on
split between PGA and Tour).
19. See id. (chronicling evolution of PGA); see also Awtrey, supra note 18.
20. See id. (noting split between PGA of America and Tour); see also Awtrey,
supra note 18.
21. See Doug Ferguson, PGA Tour Begins New Era with Drug Testing, USA TODAY
(July 2, 2008, 5:21 PM), http://usatoday30.usatoday.com/sports/golf/2008-07-02-
630332920_x.htm (concluding golf has finally entered modern age with Anti-Dop-
ing Program and testing).
22. See id. (revealing drastically different opinions of policy on Tour).
23. See id. (noting difference between professional golf and other sports).
24. Id. (noting reluctance of Tour to implement Anti-Doping Program).
25. See id. (describing logistics of implementing Anti-Doping Program); see
also Stephen Hennessey, John Daly Calls Randomness of PGA Tour’s Drug-Testing Policy
“a Joke,” GOLF DIGEST (Mar. 11, 2015), http://www.golfdigest.com/blogs/the-
loop/2015/03/john-daly-calls-pga-tours-drug.html (citing John Daly, Tour player,
questioning random nature of Tour’s drug-testing).
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transparency, which was lacking in the past.26  However, these ex-
pectations of the Tour have remained unfulfilled.27  Instead, the
cloak of secrecy surrounding the Tour, and the controversy that
follows, has engulfed the Anti-Doping Program from the outset.28
In 2009, tour player Doug Barron tested positive for synthetic
testosterone and became the first player suspended under the new
Anti-Doping Program.29  Interestingly, Barron had been taking syn-
thetic testosterone for four years prior to the Anti-Doping Program
to treat his low levels of testosterone but was denied an exemption
by the Tour, forcing him to quit taking it when the Anti-Doping
Program began.30  Nevertheless, a few weeks before his only tourna-
ment on the Tour that year, and after consulting with his doctors,
Barron decided to take a shot of synthetic testosterone to return his
testosterone to normal levels because he had been feeling very le-
thargic.31  Unfortunately, Barron was randomly tested at the tour-
nament and failed the test.32  He decided not to appeal, filed a
lawsuit that was later settled, and served a one-year suspension.33
Ironically, upon returning from his suspension the Tour granted
him a medical exemption to continue taking synthetic
testosterone.34
Another Anti-Doping Program controversy involved the Tour
player Mark Calcavecchia in 2011.35  During 2011, Calcavecchia had
26. See Karen Crouse, An Admission by Singh, an Opportunity for the Tour, N.Y.
TIMES (Jan. 30, 2013), http://www.nytimes.com/2013/01/31/sports/golf/an-ad
mission-by-singh-an-opportunity-for-the-pga-tour.html (declaring Vijay’s admission
an opportunity for Tour to provide full transparency on Anti-Doping Program and
implementation).
27. See id. (revealing Tour’s missed opportunity for greater transparency with
investigation of Vijay).
28. See Matthew Rudy, The PGA Tour’s Pretend Drug Policy, GOLF DIGEST (Aug.
1, 2014), http://www.golfdigest.com/blogs/the-loop/2014/08/column-the-pga-to
urs-pretend-d.html (critiquing Anti-Doping Program for lacking transparency).
29. See Doug Ferguson, Drug Suspension Lifted, Barron Heads to Q-School to Try to
Regain Status, PGA (Nov. 15, 2010, 6:07 PM), http://www.pga.com/drug-suspen-
sion-lifted-doug-barron-heads-q-school-try-regain-status (reporting Barron as first
person disciplined under new Anti-Doping Program).
30. See id. (recounting why Barron was taking synthetic testosterone).
31. See id. (detailing events leading up to failed drug test).
32. See id. (reporting Barron’s failed drug test).
33. See id. (noting Barron’s reaction to failed test).
34. See id. (observing Barron was later granted medical exemption to take syn-
thetic testosterone).
35. See Craig Dolch, The First Golfer to Use Deer-Antler Spray from S.W.A.T.S? It’s
Not Who You Think, YAHOO! SPORTS (May 10, 2013, 8:59 AM), http://sports.yahoo
.com/news/first-golfer-deer-antler-spray-125900248—golf.html (providing back-
ground on other players who used deer antler spray); see also Adam Watson & Eric
Adelson, PGA Tour Cracks Down On Deer Antler Spray, THE POST GAME (Aug. 11,
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been dealing with frequent back and wrist issues, so he began using
a spray containing a substance called IGF-1 from the company
“Sports With Alternatives to Steroids” (“SWATS”).36  Although the
Tour does not test for IGF-1, once the Tour realized Calcavecchia
was using the spray it immediately told him to stop.37  Later in 2011,
the Tour issued a warning to all players about the prohibited ingre-
dients in the spray.38  Interestingly, Calcavecchia did not receive
any punishment for his use of the banned substance.39
Yet another intriguing controversy surrounds one of the best
young players in the game of golf, Dustin Johnson.40  Johnson mys-
teriously missed time in 2012, which he attributed to a back injury
from lifting a jet ski, and also returned to action in February 2015
after a six-month hiatus, which he attributed to personal strug-
gles.41  During Johnson’s recent six-month break, the Tour even is-
sued a statement saying Johnson was not suspended.42  However,
multiple reports speculated that Johnson’s six-month absence from
the Tour was due to testing positive for cocaine, supposedly his
third failed drug test since turning professional.43  Within a month
of Johnson’s return to the Tour he won the WGC-Cadillac Champi-
2011), http://www.thepostgame.com/features/201108/pga-tour-cracks-down-
deer-antler-spray (referencing another similar drug issue on Tour).
36. See Watson & Adelson, supra note 35 (describing spray and company).
The spray produced by this company was the same that Vijay would later use. See
id.
37. See id. (describing Tour’s action directing Calcavecchia to stop taking
spray).
38. See Jason Sobel, Singh Admits to Using Spray, ‘Shocked’ it Contains Banned
Substance, GOLF CHANNEL (Jan. 30, 2013, 1:50 PM), http://www.golfchannel.com/
news/golftalkcentral/singh-admits-using-spray-shocked-it-contains-banned-sub-
stance/ (citing Tour’s press release warning players about use of spray).
39. See Michael McCann, Vijay Singh v. PGA Tour: Why Singh Sued and How the
Tour Will Fight Back, GOLF MAGAZINE (May 8, 2013), http://www.golf.com/tour-
and-news/vijay-singh-sues-pga-tour-over-alleged-ped-policy-violation (observing
Calcavecchia’s actions did not warrant suspension).
40. See Rudy, supra note 28 (listing Johnson’s suspect absences from tour and
reports that he failed three drug tests).
41. See Jason Sobel, DJ’s Past in Spotlight with Reported Suspension, GOLF CHAN-
NEL (Aug. 1, 2014, 6:45 PM), http://www.golfchannel.com/news/jason-sobel/djs-
troubled-past-spotlight-latest-drug-suspension/ (questioning Johnson’s excuses for
missing significant playing time); see also Rudy, supra note 28 (reporting Johnson
was suspended by Tour for third failed drug test).
42. See Sobel, supra note 41 (noting Tour’s insistence Johnson was not sus-
pended during six-month hiatus); see also Rudy, supra note 28 (disagreeing with
Tour’s insistence Johnson was not suspended).
43. See Sobel, supra note 41 (citing various sources confirming Johnson was
suspended by Tour); see also Rudy, supra note 28 (presenting sources confirming
Johnson was suspended after his third failed drug test including two others occur-
ring in 2009 for marijuana and 2012 for cocaine).
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onship, and then a few months later he tied for second at the 2015
U.S. Open, only fueling speculation surrounding his absence.44
The latest controversy involving the Anti-Doping Program oc-
curred on July 7, 2015 when Scott Stallings, a three-time winner on
the Tour, was suspended ninety days for violating the Anti-Doping
Program.45  In late 2014, Stallings began suffering serious fatigue
that made finishing a round of golf difficult.46  After consulting
with his doctor, who urged him to check with the Tour for compli-
ance, Stallings began taking dehydroepiandrosterone (“DHEA”) to
help with his chronic fatigue issues, not in an attempt to gain a
competitive advantage.47  However, Stallings did not review the
Tour’s list of banned substances and took DHEA for about two
months without knowing it was banned by the Tour.48  During the
two-month period that Stallings took DHEA he was drug tested by
the Tour and passed the drug test.49  Stallings later attended a semi-
nar by the Tour regarding banned substances, realized the Tour
banned DHEA, and immediately self-reported the violation.50  As a
result of the violation, Stallings was suspended for ninety days span-
ning from July 7 to October 7, 2015, even though he passed a drug
test while taking the banned substance, and then self-reported his
inadvertent violation.51
44. See Sam Weinman, Tim Finchem Says Most Golf Fans “Don’t Really Want to
Know” About Player Discipline. Do You Agree?, GOLF DIGEST (Mar. 10, 2015), http://
www.golfdigest.com/blogs/the-loop/2015/03/tim-finchem-says-most-golf-fan.html
(noting speculation likely to follow Johnson incident); see also Sacha Pisani, Dustin
Johnson Rallies to Win WGC-Cadillac Championship, SPORTING NEWS (Mar. 8, 2015),
http://www.sportingnews.com/sport-news/4637966-dustin-johnson-wgc-cadillac-
championship-miami-score-results-final-round-bubba-watson-rory-mcilroy (report-
ing Johnson’s win within a month of his return).
45. See Sean Zak, Scott Stallings Suspended by PGA Tour Under Anti-Doping Policy,
GOLF MAGAZINE (July 7, 2015), http://www.golf.com/tour-and-news/scott-stallings-
suspended-pga-tour-under-anti-doping-policy (reporting Stallings’ suspension by
Tour).
46. See Rex Hoggard, Stallings’ Case Further Highlights Tour’s Anti-Doping Inade-
quacy, GOLF CHANNEL (Jul. 8, 2015, 1:30 PM), http://www.golfchannel.com/news/
rex-hoggard/stallings-case-further-highlights-tours-anti-doping-inadequacy/
(describing Stallings’ medical situation prior to doping violation).
47. See Zak, supra note 45 (highlighting Stallings’ off course health issues);
Hoggard, supra note 46 (noting Stallings’ intent); see also DHEA, MEDLINEPLUS
(June 9, 2015), https://www.nlm.nih.gov/medlineplus/druginfo/natural/331
.html (describing DHEA).
48. See Hoggard, supra note 46 (reporting that Stallings did not review Tour’s
banned substances list prior to using DHEA).
49. See id. (reporting that Stallings passed Tour drug test while taking DHEA).
50. See id. (reporting that Stallings self-reported violation).
51. See Zak, supra note 45 (detailing length of suspension).
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Stallings’ violation and subsequent suspension resembles
Vijay’s situation because both admitted to using a banned sub-
stance, “both took substances that many argue have no perform-
ance enhancing benefit if taken orally[,] and neither failed a drug
test.”52  Some players including Phil Mickelson, a star on the Tour,
defended Stallings’ right to take DHEA because the goal was to im-
prove his overall health and not performance enhancement.53
Therefore, Mickelson believed the penalty did not fit the crime and
was too harsh considering Stallings’ intent.54
This recent Stallings incident propelled the Tour’s Anti-Dop-
ing Program back into the spotlight.  Some critics of the Anti-Dop-
ing Program believe the Tour missed an opportunity to deviate
from the guidelines and lessen the penalty by considering Stallings’
intent as a mitigating factor.55  Furthermore, the Tour had previ-
ously diverged from the mainstream approach when it did not fully
implement the World Anti-Doping Agency’s (“WADA”) list of
banned substances when launching its Anti-Doping Program in
2008.56  Additionally, worldwide anti-doping regulation is typically
characterized by full transparency throughout the process.57
Although the Tour’s Anti-Doping Program sought to convey
transparency, it failed because of its policy to only disclose viola-
tions for performance enhancing drugs and not violations for recre-
ational drug use.58  Furthermore, the Tour’s management of Vijay’s
situation shows that the Anti-Doping Program lacks not just trans-
52. Hoggard, supra note 46 (drawing similarities between Stallings and Vijay
incidents).
53. See id. (listing Tour players defending Stallings). Mickelson observed:
“[Stallings] was, in my opinion, trying to help his overall health, doing something
that every other citizen in the country has the right to do, and it was taken away
from him because he plays golf for a living and I don’t necessarily agree with that.”
Id. (quoting June 2015 statement by Mickelson).
54. See id. (quoting statements by Tour players who opposed length of Stall-
ings’ punishment).
55. See, e.g., id. (portraying Stallings’ situation as another mistake by Tour re-
garding Anti-Doping Program).
56. See id. (“When the Tour introduced testing in 2008 it didn’t fully follow
the WADA list of banned substances or the hallmark transparency that defines the
global effort to end doping.”).
57. See id. (explaining irony that Tour’s Anti-Doping Program is unique for its
lack of transparency).
58. See Rudy, supra note 28 (observing Tour’s lack of transparency for Anti-
Doping Program violations); see also Pete Madden, Tour Considers Changes to Policy
on Reporting Conduct Violations, GOLF MAGAZINE (Mar. 10, 2015, updated Mar. 11,
2015), http://www.golf.com/tour-and-news/pga-tour-considers-changes-policy-re-
porting-conduct-violations (noting discrepancy by Tour in reporting violations of
Anti-Doping Program).
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parency but also clarity.59  As golf’s return to the Olympics in Sum-
mer 2016 draws closer, the rift between anti-doping testing in golf,
compared to other sports, continues to widen.60
B. The Tour’s Current Anti-Doping Program Manual
The Tour’s Anti-Doping Program Manual (“the Manual”) ex-
tensively details the rules and regulations of the Anti-Doping Pro-
gram.61  The Anti-Doping Program applies to all current members
of the Tour as well as participants in any event co-sponsored by the
Tour.62  The banned substances are listed in Section 4 of the Man-
ual and are occasionally amended by the Tour.63  The Manual also
clearly states that all players are strictly liable for ingestion of pro-
hibited substances.64  As a result, any player found with a prohibited
substance in his or her body, regardless of intent, has committed a
doping violation.65  Possible sanctions for violating the Manual in-
clude disqualification, forfeiture of prize money, and fines.66  Im-
portantly, the Manual also makes admitting conduct that violates
the Anti-Doping Program a violation.67
C. Vijay’s Saga
Vijay’s whirlwind journey began when a Sports Illustrated story
hit the press on January 28, 2013.68  In the article, Vijay admitted
taking a product called deer antler spray on a frequent basis.69
59. See DiMeglio, supra note 7 (revealing questions about Tour’s implementa-
tion of Anti-Doping Program as evidenced in Vijay’s lawsuit).
60. See id. (observing golf’s struggle to maintain acceptable anti-doping prac-
tices as it prepares for upcoming Olympics).
61. See PGA TOUR ANTI-DOPING PROGRAM MANUAL (Jan. 2009), available at
http://assets.sbnation.com/assets/208240/PGATOURANTI-DOPINGPROGRAM-
MANUAL2009_1_.pdf (providing Manual).
62. See id. at 3 (discussing who is subject to Anti-Doping Program).
63. See id. at 21–25 (listing banned substances).
64. See id. at 3 (stating players are strictly liable for using any prohibited sub-
stances “regardless of how the prohibited substance” enters the body).
65. See id. (explaining consequences of strict liability for players).
66. See id. at 15–16 (detailing sanctions for violations).
67. See id. at 8–9 (admitting to violation is violation); see also id. at 3 (“[I]f the
PGA Tour becomes aware you have used a prohibited substance, including if by
your own admission, you have committed a doping violation regardless of how the
prohibited substance entered your body.”).
68. See Bob Harig, Vijay Could Face Suspension, ESPN (Jan 30, 2013), http://
espn.go.com/golf/story/_/id/8897822/vijay-singh-admits-use-banned-substance-
deer-antler-spray (detailing Sports Illustrated article where Vijay admitted he used
deer antler spray); see also Crouse, supra note 26 (discussing Vijay’s admission in
Sports Illustrated article).
69. See Harig, supra note 68 (describing Vijay’s frequent use of deer antler
spray); see also Dina Spector, Deer Antler Spray: The Natural Supplement That Seems Too
8
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Vijay received the product in November 2012 from SWATS and, in
a statement coinciding with the article’s publication, said he
checked the list of ingredients in an attempt to avoid violating the
Anti-Doping Program.70  However, deer-antler spray contained IGF-
1, a “natural, anabolic hormone that stimulates muscle growth”
which is banned under the Tour’s Anti-Doping Program.71  As a
result of Vijay’s admission, the Tour immediately began an investi-
gation.72  Intriguingly, the Tour does not test for IGF-1 because it
does not believe the testing is sufficiently reliable.73  However, the
Tour’s Anti-Doping Program does not consider intent a defense to
a violation.74  Since Vijay admitted taking a banned substance, al-
though unknowingly, it was still a violation of the Anti-Doping
Program.75
The Tour’s investigation of Vijay spanned nearly three
months.76  First, the Tour tested the deer-antler spray provided by
Vijay to determine whether it contained IGF-1.77  After testing, the
Good to Be True, BUSINESS INSIDER (May 15, 2013, 1:07 PM), http://www.businessin-
sider.com/what-is-deer-antler-spray-2013-5 (describing deer antler spray as product
many professional athletes “use as a ‘steroid alternative’ to improve muscle
strength or boost energy”).
70. See Harig, supra note 68 (noting Vijay’s review after receiving product).  In
a statement released by the PGA Tour on January 30, 2013, Singh stated:
While I have used deer-antler spray, at no time was I aware that it may
contain a substance that is banned under the PGA Tour Anti-Doping pol-
icy. In fact, when I first received the product, I reviewed the list of ingre-
dients and did not see any prohibited substances.
Id.
71. Id. (reporting deer antler spray contains banned substance IGF-1).
72. See id. (reporting Tour’s immediate reaction to Vijay’s admission).
73. See id. (reporting that Ty Votaw, PGA Tour Vice President of Communica-
tions and International Affairs, said “the tour does not test for IGF-1 nor human
growth hormone because it does not feel comfortable with the reliability of such
testing”).
74. See PGA TOUR ANTI-DOPING PROGRAM MANUAL, supra note 61, sec.
2(D)(1)(a) (providing that “intent, fault, negligence or knowing use” of prohib-
ited substances “is not necessary” to establish anti-doping violation).
75. See id. at 8–9.  As relevant to Vijay’s situation, the Manual provides:
It is each player’s personal duty to ensure that no Prohibited Substance en-
ters his body.  Players are responsible for any Prohibited Substance or its
Metabolites or Markers found to be present in their samples.  Accordingly,
it is not necessary that intent, fault, negligence or knowing use on the
player’s part be demonstrated in order to establish an anti-doping viola-
tion under Section D(1) . . . .
Id. at 8 (Section 2 (D)(1)(a)).  Prohibited conduct includes: “Admissions by a
player of any of the conduct listed in Sections (1)–(7) above.” Id. at 9 (Section 2
(D)(8)).
76. See PGA Tour Statement Regarding Vijay Singh, PGA TOUR (Apr. 30, 2013),
http://www.pgatour.com/news/2013/04/30/pga-tour-statement-regarding-vijay-
singh.html (detailing Tour’s statement regarding Vijay).
77. See id. (outlining steps of Tour’s investigation of Vijay).
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Tour confirmed it did contain the banned substance IGF-1.78  As a
result, the Tour privately informed Vijay that he would be sus-
pended for ninety-day but did not reveal this sanction to the pub-
lic.79  Vijay then appealed the ninety-day suspension and was
permitted to play while the investigation and appeals process
moved forward.80  As a result, the Tour continued its reputation for
lacking transparency when the commissioner, discussing the investi-
gation of Vijay’s possible violation, stated, “[i]f no action is taken, it
won’t be reported.”81 Interestingly, the Tour investigated the mat-
ter for almost three months before it finally contacted WADA,
which administers the Tour’s Anti-Doping Program, with specific
questions about IGF-1.82  In response to this inquiry, on April 30,
2013, WADA wrote:
In relation to your pending IGF-1 matter, it is the po-
sition of WADA, in applying the Prohibited List, that the
use of “deer antler spray” (which is known to contain small
amounts of IGF-I) is not considered prohibited.
On the other hand, it should be known that Deer
Antler Spray contains small amounts of IGF-1 that may af-
fect anti-doping tests.
Players should be warned that in the case of a positive
test for IGF-1 or hGH, it would be considered an Adverse
Analytical Finding.83
As a result of this instruction, the Tour issued a statement re-
counting the details of Vijay’s admission and the ensuing investiga-
tion.84  The Tour said that it deferred to WADA’s role in
administering the Anti-Doping Program and decided not to charge
Vijay with a violation, dropped the investigation and all related
78. See id. (detailing results of Tour’s testing of deer antler spray).
79. See Mark Sandritter, Top 25 Golf Stories of 2013, No. 17: Vijay Singh ‘Sus-
pended’ For PED’s, Sues PGA Tour, SB NATION (Dec. 1, 2013, 8:32 AM), http://www
.sbnation.com/golf/2013/12/1/5159208/vijay-singh-peds-suspension-lawsuit-pga-
tour-top-moments-2013 (reporting that Vijay’s “lawsuit also revealed the fact the
PGA Tour did sanction Singh, previously unknown to the public”).
80. See id. (including report that Vijay appealed suspension).
81. Id. (quoting Tour Commissioner revealing Tour’s lack of transparency).
82. See id. (revealing intricacy between Tour’s policy and WADA); see also Rex
Hoggard, Singh’s Battle Against the Tour Comes into Focus, GOLF CHANNEL (Nov. 10,
2015, 2:16 PM) http://www.golfchannel.com/news/rex-hoggard/singhs-battle-
against-tour-comes-focus/ (indicating Tour waited three months to contact WADA
for clarification).
83. PGA Tour Statement Regarding Vijay Singh, supra note 76 (quoting WADA’s
response to questions from Tour regarding deer antler spray).
84. See id. (reporting Tour’s statement regarding Vijay investigation).
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sanctions.85  The Tour’s statement reaffirmed Vijay’s cooperation
throughout the investigation.86  The Tour also used the platform to
remind players they will be held responsible if they take a prohib-
ited substance regardless of their intent.87  In concluding, the state-
ment sternly cautioned players to be proactive in avoiding banned
substances, and specifically cited the warning issued by the Tour in
August 2011 regarding deer antler spray.88
D. Singh v. PGA Tour: The Lawsuit
After the Tour dropped its sanctions against Vijay on April 30,
2013, everyone believed the drama was over.89  However, just one
week later on May 8, 2013, Vijay sent a shockwave through the golf
world when he filed a lawsuit against the Tour for its mismanage-
ment of the allegations and investigation.90  Vijay filed the lawsuit
in New York Supreme Court alleging seven separate causes of ac-
tion against the Tour.91
1. The Allegations
Of the seven separate counts Vijay filed against the Tour, the
first three causes of action were negligence based.92  First, Vijay as-
serted that the Tour failed to determine whether the spray was a
banned substance under the Anti-Doping Program.93  Second, Vijay
claimed the Tour disciplined him in an unprecedented fashion
without having first tested the effectiveness of the substance.94
Third, he alleged that the method of discipline was unjust because
the Tour knew Vijay had never tested positive for a banned sub-
stance.95  Fourth, Vijay claimed that the Tour breached its implied
covenant of good faith and publicly degraded his reputation be-
cause the Tour failed to conduct a fair investigation before disci-
85. See id. (acknowledging Tour’s conclusion to drop sanctions against Vijay).
86. See id. (indicating Vijay was cooperative throughout investigation).
87. See id. (“While there is no reason to believe that Mr. Singh knowingly took
a prohibited substance, the PGA TOUR Anti-Doping Program clearly states that
players are responsible for use of a prohibited substance regardless of intent.”).
88. See id. (suggesting players are responsible for preventing any violations).
89. See DiMeglio, supra note 7 (reporting ensuing drama after Vijay was ab-
solved of wrongdoing).
90. See id. (reporting Vijay’s lawsuit against Tour).
91. See Singh v. PGA Tour, Inc., No. 651659/2013, 2014 WL 641311 (N.Y.
Sup. Ct. N.Y. Cnty. Feb. 13, 2014).  The New York Supreme Court is the state’s trial
court.
92. See id. at *3–4 (describing three negligence causes of action).
93. See id. (discussing first negligence cause of action).
94. See id. (discussing second negligence cause of action).
95. See id. (discussing third negligence cause of action).
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plining him, failed to analyze the substance, failed to follow the
Manual, and delayed announcing that he would not be disci-
plined.96  Fifth, Vijay alleged that the Tour breached its fiduciary
duty to responsibly administer the Anti-Doping Program, and sixth
that the Tour committed intentional infliction of emotional distress
when handling the investigation.97  Finally, Vijay alleged conversion
by the Tour because it held his winnings in escrow until the investi-
gation concluded.98
2. Initial Ruling to Dismiss Allegations
On June 12, 2013, the Tour moved to dismiss Vijay’s lawsuit,
and oral arguments occurred on October 24, 2013.99  On February
13, 2014, Judge Eileen Bransten granted the Tour’s motion to dis-
miss in part and denied it in part.100  The court dismissed all three
causes of action for negligence because they were contractual in
nature and, as such, could not support a negligence claim.101
Next, the court denied the defendant’s motion to dismiss the
fourth cause of action for breach of implied covenant of good faith
and fair dealing.102  The court found that Vijay’s allegations were
sufficient to avoid dismissal because he alleged that the Tour incon-
sistently disciplined golfers who admitted to using the spray, specifi-
cally citing Calcavecchia as an example.103  Vijay also alleged that
96. See id. at *4–5 (discussing fourth cause of action for breach of implied
covenant of good faith and fair dealing).
97. See id. at *5–9 (discussing fifth cause of action for breach of fiduciary duty,
and sixth cause of action for intentional infliction of emotional distress).
98. See id. at *9–10 (discussing seventh cause of action for conversion).
99. See Singh, 2014 WL 641311 (ruling on PGA Tour’s motion to dismiss);
Alex Miceli, Singh’s Lawyers Argue Why Lawsuit Can Stand, GOLFWEEK (Nov. 8, 2013),
http://golfweek.com/news/2013/nov/06/pga-tour-vijay-singh-lawsuit-should-not-
be-dismiss/ (reporting on October 24, 2013 oral arguments, and describing Vijay’s
arguments against dismissal); see also Ryan Ballengee, PGA Tour Has Filed Motion to
Dismiss Vijay Singh Lawsuit, GOLF NEWS NET (June 20, 2013), http://thegolfnewsnet
.com/ryan_ballengee/2013/06/20/pga-tour-filed-motion-dismiss-vijay-singh-law-
suit-3324/ (outlining Tour’s motion to dismiss).
100. See Singh, 2014 WL 641311 (ruling on Tour’s motion to dismiss).
101. See id. at *3–4 (dismissing negligence causes of action because alleged
duties were “contractual in nature” and could not establish prima facie claims for
negligence).
102. See id. at *4–5 (denying Motion to dismiss claim for breach of implied
covenant and fair dealing).
103. See id. at *5.  The Court explained:
Plaintiff alleges that Defendant has inconsistently disciplined golfers who
admitted using deer antler spray.  Specifically, Plaintiff alleges that in
2011, golfer Mark Calcavecchia also admitted that he used deer antler
spray and was not disciplined by Defendant.  Rather, Calcavecchia was
merely told to stop using the spray.  In addition, Plaintiff alleges, upon
information and belief, that Defendant “is aware of other golfers who
12
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the Tour knew other golfers used the spray but did not discipline
them.104  Further, Vijay asserted that the Tour did not fairly investi-
gate the spray he used before deciding he committed a violation.105
Vijay claimed that the Tour’s approach led to procedural missteps,
which included suspending Vijay and placing his earnings in es-
crow.106  Finally, Vijay claimed that the Tour delayed reversal of his
penalties even though it knew WADA removed the spray from its
banned substances list.107  Due to the circumstances of a motion to
dismiss, the court accepted Vijay’s allegations as true and found
that he had pled facts sufficient for a cause of action for breach of
implied covenant of good faith and fair dealing.108
The court granted the motion to dismiss for breach of fiduci-
ary duty because it was analogous to the fourth cause of action and
Vijay did not meet the particularized pleading requirement.109  Spe-
cifically, Vijay failed to demonstrate the fiduciary relationship be-
tween him and the Tour, and failed to show a breach of that alleged
fiduciary relationship.110  The court also dismissed the cause of ac-
tion for intentional infliction of emotional distress because the con-
duct did not rise to the level of extreme and dangerous, as required
under New York law.111
Finally, the court denied the motion to dismiss the last cause of
action for conversion.112  Vijay alleged that the Tour held his prize
money in violation of Section 2 (H)(5) of the Manual.113  The Man-
have used the Spray but has not attempted to discipline those other
golfers.”
Id. (internal citations omitted).
104. See id. (“In addition, Plaintiff alleges, upon information and belief, that
Defendant ‘is aware of other golfers who have used the Spray but has not at-
tempted to discipline those other golfers.’”).
105. See id. (alleging that Tour “failed to fairly and thoroughly investigate”).
106. See id. (noting Tour’s alleged procedural mistakes).
107. See id. (alleging that Tour purposely delayed reversal of penalties).
108. See id. (reasoning why Vijay’s allegations were sufficient to survive dismis-
sal at this stage).  On a Motion to dismiss under New York’s Civil Practice Law and
Rules, the court “accept[s] the facts as alleged in the complaint as true, accord[s]
plaintiffs the benefit of every possible favorable inference, and determine[s] only
whether the facts as alleged fit within any cognizable legal theory.” Id. (quoting
Leon v. Martinez, 638 N.E.2d 511, 513 (N.Y. 1994)).
109. See id. at *5–7 (dismissing claim for breach of fiduciary duty).
110. See id. at *7 (describing two prongs for breach of fiduciary duty Vijay
failed to satisfy).
111. See id. at *8–9 (dismissing claim for intentional infliction of emotional
distress).
112. See id. at *9–10 (denying motion to dismiss conversion claim).
113. See id.; see also PGA TOUR ANTI-DOPING PROGRAM MANUAL, supra note 61,
at 12 (stating if administrator believes player may have committed violation, player
must be notified of potential violation).
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ual states that the player is given seven days from the time of notifi-
cation to provide a written explanation of their conduct.114
Suspected players are permitted to continue playing, but if a “player
chooses to continue participating in any tournaments pending the
resolution of the case, then any prize money won by the player may
be held in escrow pending the outcome of the case.”115  Vijay
claimed that the Tour placed his money in escrow prior to giving
him proper notice.116  Furthermore, Vijay said the Tour notified
him by letter dated February 14, 2013 that he violated the Anti-
Doping Program.117  However, he received another letter February
19, 2013 stating that his prize money had been held in escrow since
his participation in a tournament that occurred February 7-10.118
As a result, the court found the allegations sufficient to avoid dis-
missal at this stage because Vijay pled facts, which would establish
that the Tour did not properly notify Vijay prior to holding his
earnings in escrow.119  In the end, Vijay’s two causes of action that
survived dismissal on the pleadings were for breach of implied cove-
nant of good faith and fair dealing and conversion.120
3. Discovery Process: Searching the Weeds
On June 12, 2014, the court granted in part and denied in part
Vijay’s motion to compel disclosure of specific documents and
materials.121  The first category of information Vijay hoped to dis-
cover contained numerous documents related to the Tour’s treat-
ment of other players suspected of using deer antler spray.122  The
court granted this motion to compel, but excluded items deemed
114. See id. at 10 (quoting PGA TOUR ANTI-DOPING PROGRAM MANUAL, supra
note 61, sec. 2H(5) (citing specific language from Manual regarding notice re-
quirements and funds in escrow).
115. Id. at 9 (quoting PGA TOUR ANTI-DOPING PROGRAM MANUAL, supra note
61, sec. 2(L)) (citing specific language from Manual regarding requirements for
keeping funds in escrow).
116. See id. at *9–10 (describing allegations supporting claim for conversion).
117. See id. at *10 (citing first letter received by Vijay).
118. See id. (observing inconsistency between Tour’s notice policy and letters
Vijay received).
119. See id. (“Because Plaintiff alleges that some of the prize money was held
in escrow prior to that notice [on February 14], Plaintiff has sufficiently alleged a
cause of action for conversion as to that money only.”).
120. See id. at *14–15 (indicating claims that survived dismissal).
121. See Singh v. PGA Tour, Inc., No. 651659/2013, 2014 WL 2650078 (N.Y.
Sup. Ct. N.Y. Cnty. June 12, 2014) (announcing decision regarding discovery
motions).
122. See id. at *1–3 (referencing Vijay’s motion to compel records of other
players suspected of using spray).
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beyond the scope of Vijay’s allegations.123  The second category for
discovery focused on the drafting history of the Tour’s Manual.124
The third category related to discovering how involved members of
the Tour were in drafting the Tour membership renewal form.125
The court denied Vijay’s motion to compel discovery of all informa-
tion contained within the second and third categories, granting
only the release of information concerning the implementation of
the Anti-Doping Program, specifically regarding IGF-1.126  The
court denied the motion to compel discovery for the final category
of information, related to a substance containing IGF-1, because it
was not on the Tour’s list of banned substances.127  Judge Eileen
Bransten then scheduled a status conference on October 7, 2014.128
The status conference proceeded as scheduled, with document pro-
duction slated to conclude in October, and another status confer-
ence set for February 2015.129
The February 2015 status conference revealed the chaos sur-
rounding the discovery process, which was originally scheduled to
close by May 30, 2015 but instead continued into the fall of 2015.130
At the point of the February 2015 status conference Vijay had de-
posed eleven witnesses, including employees of the Tour, execu-
tives from WADA, and Calcavecchia.131  However, following the
February 2015 status conference both parties continued discovery
123. See id. at *3 (allowing some, but not all, discovery Vijay requested).
124. See id. at *3–4 (discussing Vijay’s discovery request for documents related
to drafting of Anti-Doping Program).
125. See id. (discussing Vijay’s discovery request aimed at Tour member in-
volvement in renewal form).
126. See id. at *4 (limiting most discovery related to this category).
127. See id. at *4–5 (denying motion to compel discovery related to substance
not on banned list).
128. See id. at *6 (announcing next procedural steps for case).
129. See Rex Hoggard, Singh’s Lawsuit Still Hung Up in Legal Procedures, GOLF
CHANNEL (Oct. 16, 2014, 12:31 PM), http://www.golfchannel.com/news/golf-
central-blog/singhs-lawsuit-still-hung-languid-legal-procedures/ (reporting status
of lawsuit in October 2014 and acknowledging that litigation is moving slowly).
130. See Rex Hoggard, Discovery Process In Singh Lawsuit Turns Hectic, GOLF
CHANNEL (Feb. 23, 2015, 3:38 PM), http://www.golfchannel.com/news/golf-cen
tral-blog/discovery-process-singh-lawsuit-turns-hectic/ (reporting progress of in-
tense discovery process); Pete Madden, Vijay Singh Deposes Mark Calcavecchia In Suit
Against Tour, GOLF (Feb. 26, 2015), http://www.golf.com/tour-and-news/vijay-
singh-deposes-two-champions-tour-pros-suit-against-tour (detailing specific jobs of
witnesses already deposed including lead drafter of WADA Code, Director General
of WADA, and Vice President of Tour Operations at Cleveland Golf); see also
Docket, Singh v. PGA Tour, Inc., No. 651659/2013 (N.Y. Sup. Ct. N.Y. Cnty. filed
May 8, 2013) (providing large number of discovery filings, court filings, and court
orders through November 27, 2015).
131. See Madden, Vijay Singh Deposes Mark Calcavecchia in Suit Against Tour,
supra note 130 (outlining Vijay’s concluded depositions).
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and filed exhibits, letters, emails, and other correspondence
throughout the summer.132  As the discovery process wore on both
parties attended status conferences in March, June, and Septem-
ber.133  Furthermore, in November the Tour submitted a motion
for summary judgment.134  Finally, on November 27, 2015, Judge
Eileen Bransten denied the Tour’s motion for summary judgment
and set the trial date for April 5, 2016.135
III. ANALYSIS
A. New York’s Implied Covenant of Good Faith
and Fair Dealing
All contracts in New York “imply a covenant of good faith and
fair dealing” between the parties, which encompasses “any promises
which a reasonable person in the position of the promisee would be
justified in understanding were included.”136 Additionally, when
the implementation of a contract requires discretion, the promisor
may not “act arbitrarily or irrationally in exercising that discre-
tion.”137  As a result, a party breaches the covenant when they act
“in a manner that deprives the other party of the right to receive
benefits under their agreement.”138
At trial Vijay will argue that the Tour was inconsistent in its
disciplinary actions against golfers who admitted to using deer ant-
ler spray.139  The court will then review the Manual to determine
132. See Docket, supra note 130.
133. See id.
134. See id.
135. See id. (noting summary judgment motions denied and trial date set).
136. Singh v. PGA Tour, Inc., No. 651659/2013, 2014 WL 641311, at *4 (N.Y.
Sup. Ct. N.Y. Cnty. Feb. 13, 2014) (quoting 511 W. 232nd Owners Corp. v. Jennifer
Realty Co., 773 N.E.2d 496, 501 (N.Y. 2002); Rowe v. Great Atl. & Pac. Tea Co., 385
N.E.2d 566, 569 (N.Y. 1978)).
137. Id. (quoting Dalton v. Educ. Testing Serv., 663 N.E.2d 289, 291 (N.Y.
1995)); see also Tedeschi v. Wagner Coll., 404 N.E.2d 1302, 1305 (N.Y. 1980)) (not-
ing “the implied in law condition of good faith [in contracts], i.e., not to act
arbitrarily).
138. David Rich, What Are the Elements of Breach of Implied Contract of Good Faith
and Fair Dealing in New York?, N.Y. BUS. LITIG. AND EMP’T ATT’YS BLOG (July 11,
2014), http://www.davidrichlaw.com/what-are-the-elements-of-breach-of-implied-
contract-of-good-faith-and-fair-dealing-in-new-york/; see Singh, 2014 WL 641311, at
*4 (“[T]his implied obligation includes ‘a pledge that neither party shall do any-
thing which will have the effect of destroying or injuring the right of the other
party to receive the fruits of the contract.’” (quoting Dalton, 663 N.E.2d at 291));
see also 22 N.Y. JUR. 2D CONTRACTS § 227 (2016) (summarizing implied covenant of
good faith and fair dealing under New York law).
139. See Singh, 2014 WL 641311, at *5 (discussing Vijay’s arguments in support
of implied covenant of good faith and fair dealing cause of action).
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whether the Tour violated its implied covenant of good faith and
fair dealing.140  Specifically, the court will likely look to Section
2(H)(5) that allows discretion on the part of the program adminis-
trator to weigh information submitted by the player and decide
whether to move forward with the violation process.141  Vijay will
likely argue the program administrator “acted arbitrarily or irra-
tionally in exercising that discretion” afforded to the Tour by the
implied covenant of good faith and fair dealing.142
During trial the court will also likely review Section 2(K) of the
Manual, which lists possible sanctions and grants the Tour Commis-
sioner discretion in the implementation of those sanctions.143  Vijay
will likely argue that the Tour’s discretion under Section 2(K) was
arbitrary and violated New York law.144  Specifically, Vijay will cite a
2011 incident where Calcavecchia admitted to using deer antler
spray.145  However, the Tour elected to merely instruct Cal-
cavecchia to stop using the spray in lieu of any punishment.146  Fur-
ther, Vijay will cite other similar instances where the Tour did not
discipline players for using the spray.147  Finally, Vijay will argue
that the Tour failed to perform a fair investigation, and thus vio-
lated the procedural guidelines of the Tour’s Manual.148  This accu-
sation relies on the Tour’s implied covenant of good faith because
Vijay would have expected the Tour’s investigation to follow the
procedural guidelines in the Manual for a fair and thorough investi-
gation.149  Therefore, Vijay will argue that the Tour violated this
implied covenant because it did not analyze the spray before it dis-
140. See PGA TOUR ANTI-DOPING PROGRAM MANUAL, supra note 61; see also
Singh, 2014 WL 641311, at *5 (analyzing Vijay’s allegations and Manual’s
provisions).
141. See Singh, 2014 WL 641311, at *5 (reviewing Section 2(H)(5) as impor-
tant component of court’s analysis).
142. See id. at *4 (citing Dalton, 663 N.E.2d at 291) (stating legal obligations
pursuant to implied covenant of good faith and fair dealing).
143. See id. at *5 (reviewing Section 2(K) as another important component of
court’s analysis).
144. See id. (analyzing Vijay’s allegations and Manual’s provisions).
145. See id. (finding that Vijay’s allegations stated claim for breach of implied
covenant of good faith and fair dealing based in part on inconsistent discipline of
players who admitted using spray).
146. See id. (observing allegation that Calcavecchia was not penalized for us-
ing spray).
147. See id. (implying there have been other similar instances where players
were not disciplined for use of spray, although names and allegations are currently
unknown).
148. See id. (presenting Vijay’s allegations against Tour for unfair
investigation).
149. See id. at *4 (stating that under New York law, contracts include “any
promises which a reasonable person in the position of the promisee would be justi-
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ciplined him, it waited three months to contact WADA for clarifica-
tion on the issue, and it delayed dismissal of the penalties.150
B. Conversion
In the state of New York, “[a] conversion occurs when a party,
intentionally and without authority, assumes or exercises control
over personal property belonging to someone else, interfering with
that person’s right of possession.”151  The two elements of conver-
sion are “(1) the plaintiff’s possessory right or interest in the prop-
erty and (2) the defendant’s dominion over the property or
interference with it, in derogation of plaintiff’s rights.”152  Impor-
tantly, conversion of money can occur “where there is a specific,
identifiable fund and an obligation to return or otherwise treat in a
particular manner the specific fund in question.”153
At trial Vijay will argue that the Tour is liable for conversion
because it held $99,980 of his prize money in escrow, from tourna-
ments he played in while under investigation.154  However, Section
2(L) of the Manual permits the Tour to hold prize money in es-
crow.155  Specifically, it says that “[i]f a player is not Provisionally
Suspended after Notice provided in section [2(H)(5)] and the
player chooses to continue participating in any tournaments pend-
ing the resolution of the case, then any prize money won by the
player may be held in escrow pending the outcome of the case.”156
Nonetheless, the Manual requires the Tour to provide notice
to a player before placing prize money in escrow.157  The Manual
also specifies that notice must be given to the player by hand deliv-
ery, registered or certified mail with return receipt requested, or by
fied in understanding were included” (citations omitted)); see also id. at *5 (indi-
cating Vijay’s implied expectations).
150. See id. at *4–5 (citing Vijay’s allegations against Tour for breach of im-
plied covenant); see also Hoggard, supra note 82 (highlighting lengthy period until
Tour contacted WADA for clarification).
151. Id. at *9 (alteration in original) (quoting Lynch v. City of New York, 965
N.Y.S.2d 441, 446 (N.Y. App. Div. 2013)).
152. Id. (quoting Lynch, 965 N.Y.S.2d at 446).
153. Id. (quoting Thys v. Fortis Sec. LLC, 903 N.Y.S.2d 368, 369 (N.Y. App.
Div. 2010)) (specifying criteria for conversion of money).
154. See id. (describing Vijay’s argument for conversion).
155. See id. at *9–10 (citing PGA TOUR ANTI-DOPING PROGRAM MANUAL, supra
note 61) (indicating Manual allows funds to be held in escrow).
156. Id. at *9 (first alteration in original) (quoting PGA TOUR ANTI-DOPING
PROGRAM MANUAL, supra note 61, sec. 2(L)).
157. See id. at *9–10 (citing PGA TOUR ANTI-DOPING PROGRAM MANUAL, supra
note 61, sec. 2(H)(5)).
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overnight delivery service.158  Since the Tour failed to provide Vijay
with timely notice, before placing his earnings in escrow, Vijay will
cite this as evidence of conversion and seek damages.159
C. Damages for Conversion
At trial Vijay will have the opportunity to recover possible dam-
ages from the Tour for conversion related to the $99,980 of earn-
ings it held in escrow.160  The court will determine possible
damages based on “the value of the property at the time of conver-
sion, together with interest.”161  Additionally, “ ‘if [the] plaintiff ac-
cepts return of the property,’ damages may include ‘the loss flowing
from the conversion.’”162  By incorporating interest as part of dam-
ages, the court will ensure that Vijay can be fully indemnified for
his loss.163  At trial Vijay will seek damages for the lost interest and
argue that the Tour improperly held his funds in escrow and re-
fused to release them with interest.164  Although the earnings were
eventually returned to Vijay after disciplinary action was withdrawn,
he can still seek damages for interest.165  If Vijay proves his conver-
sion claim, Judge Eileen Bransten will determine the amount of
damages.166
158. See PGA TOUR ANTI-DOPING PROGRAM MANUAL, supra note 61, sec. 3, at
17 (defining “notice” as used in reference to “[a]ny notification required by the
[Anti-Doping] Program).  The Manual notes that delivery to a player’s tournament
locker also satisfies the hand delivery requirement. See id. (defining “notice”).
159. See Singh, 2014 WL 641311, at *10 (concluding that Vijay’s allegations
established he was not given proper notice under Manual).
160. See id. (finding Vijay’s conversion claim sufficient to avoid dismissal).
161. Id. at *9 (quoting Will of Rothko, 392 N.Y.S.2d 870, 874 (N.Y. App. Div.
1977)).
162. Id. (quoting Chow v. Kshel Realty Corp., No. 115033/02, slip op. at 65,
2011 WL 1748557 (N.Y. Sup. Ct., N.Y. Cnty. Apr. 27, 2011)).
163. See 23 N.Y. JUR. 2D CONVERSION, ETC. § 62 (2016) (“The purpose of dam-
ages in an action for conversion, as in any other action, is to give the injured party
full indemnity and no more. . . .  The allowance of interest is based on the theory
that it is as necessary a part of a complete indemnity to the owner of the property
as the value itself.”).
164. See Singh, 2014 WL 641311, at *9 (noting Vijay’s allegations concerning
Tour’s conversion of earnings).
165. See id. (acknowledging that return of earnings does not prevent Vijay
from suing for damages).
166. See Lager Assoc. v. City of New York, 759 N.Y.S.2d 116, 120 (N.Y. App.
Div. 2003) (“It is peculiarly within the discretion of the trier of fact to assess the
evidence and the persuasiveness of testimony as to estimates and evaluations of
damage.” (citations omitted)).
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D. Vijay’s Likelihood of Success on Implied Covenant of
Good Faith and Fair Dealing Claim
As Vijay’s case heads to trial, tensions are likely running high
because the Tour, and all its power, will face a worthy opponent.167
Vijay’s first claim before the court is for breach of the implied cove-
nant of good faith and fair dealing.168  Within that broad claim,
Vijay will likely argue four different theories on how the Tour
breached its covenant and all four will be individually analyzed by
the Court.169  First, Vijay will argue the Tour inconsistently pun-
ished golfers who used deer antler spray.170  Second, that the Tour
failed to conduct a fair investigation of the spray before disciplining
Vijay.171  Third, that the Tour disciplined Vijay without following
protocol of the Manual.172  Fourth, that the Tour delayed dismissal
of his punishment.173
Vijay’s argument regarding the Tour’s inconsistent punish-
ment of players using deer antler spray will focus primarily on Cal-
cavecchia, as well as other players.174  In 2011, the Tour instructed
Calcavecchia to stop using deer antler spray, but never issued any
punishment.175  In conjunction, Vijay will argue that the Anti-Dop-
ing Program administrator acted arbitrarily, thus violating the im-
plied covenant of good faith and fair dealing.176
While Vijay’s allegations were sufficient to overcome dismissal,
the key to winning this argument at trial will likely hinge on the
evidence collected during discovery.177  The witnesses deposed by
Vijay’s counsel include representatives of the Tour, executives from
167. See Why the PGA Tour Should Fear Vijay Singh, GOLF.COM (Mar. 5, 2014),
http://www.golf.com/video/legal-analyst-michael-mccann-discusses-vijay-singh-
lawsuit (interviewing Sports Illustrated legal analyst Michael McCann, who recog-
nized that Vijay has significant money to fight lawsuit and little motivation to
settle).
168. See Singh, 2014 WL 641311, at *5 (reviewing claim for breach of implied
covenant of good faith and fair dealing).
169. See id. (indicating Vijay’s four theories of liability).
170. See id. at *4–5 (noting Vijay’s first theory against tour).
171. See id. at *5 (noting Vijay’s second theory against tour).
172. See id. (noting Vijay’s third theory against tour).
173. See id. (noting Vijay’s fourth theory against tour).
174. See Madden, supra note 130 (noting Vijay’s deposition of Calcavecchia to
bolster “disparate treatment” argument).
175. See supra notes 35–39 and accompanying text (referencing Calcavecchia
as example of inconsistent punishment by Tour).
176. See supra notes 138–39 and accompanying text (indicating possible abuse
of discretion by Tour).
177. See supra notes 121–27 and accompanying text (noting extensive discov-
ery process curtailed by Judge).
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WADA, and Calcavecchia.178  These depositions, as well as the many
others conducted, will play a large role in this case.179  Further evi-
dence of players using the spray without facing disciplinary action
will also significantly bolster Vijay’s chances of prevailing at trial.180
However, if the depositions show no additional players who used
the spray and avoided penalties, the Tour will be able to argue the
Calcavecchia incident was isolated and the Tour simply used that
situation to warn players before it began disciplining for using this
new substance.181
Vijay’s argument that the Tour failed to fairly investigate the
spray before disciplining him will focus on his immediate suspen-
sion by the Tour based solely on his admission of use.182  It will also
focus on the fact that the suspension occurred before the Tour
tested the spray.183  However, this argument is a long way from tak-
ing Vijay to the winner’s circle because, according to the Manual
Section 2(D)(8), admitting the use of a banned substance is itself a
violation of the Anti-Doping Program.184  As a result, Vijay will likely
lose this argument at trial since the Tour had the right to suspend
him pending the investigation because he admitted violating the
Anti-Doping Program.185
At trial Vijay will argue that the Tour disciplined him without
following the Manual’s protocol by specifically citing when the
Tour placed his earnings in escrow prior to giving him proper no-
tice.186  This argument favors Vijay because the offered evidence
reveals the Tour did not provide adequate notice as required under
Section 2 (H)(5).187  The Tour will have to both disprove Vijay’s
contentions that a letter he received did not qualify as notice, and
demonstrate that it gave him adequate notice prior to placing his
earnings in escrow.188  However, the Tour seems unlikely to suc-
178. See Hoggard, supra note 130 (listing people already deposed).
179. See id. (reporting Vijay’s plans to depose additional people).
180. See id. (noting Tour’s opposition to additional depositions).
181. See id. (discussing Vijay’s plans for depositions).
182. See DiMeglio, supra note 7 (reporting Vijay’s lawsuit and its reasoning).
183. See id. (discussing critical elements of Vijay’s lawsuit).
184. See PGA TOUR ANTI-DOPING PROGRAM MANUAL, supra note 61, sec.
2(D)(8) (declaring that “[a]dmissions by a player of any . . . conduct” which consti-
tutes anti-doping rule violation is itself violation).
185. See id. sec. 2(D) (detailing prohibited conduct which “constitute[s] anti-
doping rule violations under the Program”).
186. See Singh v. PGA Tour, Inc., No. 651659/2013, 2014 WL 641311, at *4–5,
9-10 (N.Y. Sup. Ct. N.Y. Cnty. Feb. 13, 2014) (highlighting gist of Vijay’s
argument).
187. See id. at *10 (observing Manual’s notice requirement).
188. See id. at *9 (noting Tour’s possible defenses to allegations by Vijay).
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ceed on this point because it wrote the letters Vijay produced as
evidence.189  Therefore, Vijay has a strong position since the Tour
disciplined him without following the Manual’s protocol.190
Vijay’s argument that the Tour delayed dismissal of his disci-
pline is based on WADA’s removal of deer antler spray from its
banned substance list while, at the same time, the Tour had not yet
dropped its disciplinary actions against Vijay.191  Although it is un-
clear exactly when WADA dropped deer antler spray from its list it
is clear that the Tour did not contact WADA for clarification until
three months into its investigation of Vijay.192  When the Tour fi-
nally contacted WADA it was at that point that the Tour received
written confirmation from WADA that deer antler spray had been
removed from the banned substances list.193  Even though the Tour
immediately dropped its investigation of Vijay after receiving the
information from WADA it seems unusual for the Tour to investi-
gate for three months without contacting WADA for clarification.194
This evidence is critical to the outcome of the trial because the
three-month span between the investigation and communication
with WADA weighs in favor of Vijay and against the Tour because it
reveals that the Tour delayed ending its investigation by not imme-
diately contacting WADA for clarification.195
E. Vijay’s Likelihood of Success on Conversion Claim
The court will review the Tour’s action of holding Vijay’s earn-
ings, his property, in escrow without providing proper notice.196
189. See Hoggard, supra note 130 (implying evidence contrary to Vijay’s will
be difficult to find).
190. See id. (arguing Vijay has strong case based on initial evidence).
191. See Singh, 2014 WL 641311, at *5 (referencing Vijay’s main argument for
Tour’s delay).
192. See id. (inferring from evidence in case that exact date is unknown); see
also Hoggard, supra note 82 (highlighting Tour’s delayed correspondence with
WADA for clarification).
193. See PGA Tour Press Conference, Transcript of Commissioner Tim
Finchem’s Statement Regarding Vijay Singh (Apr. 30, 2013) [hereinafter Finchem
Press Conference], available at http://www.pgatour.com/what-they-said/2013/04/
29/transcript—tim-finchem.html (disputing Vijay’s claim that Tour delayed
dismissal).
194. See id. (announcing Tour’s immediate dismissal of sanctions upon receiv-
ing information from WADA); see also Hoggard, supra note 82 (highlighting Tour’s
delayed correspondence with WADA).
195. See Singh, 2014 WL 641311, at *5 (discussing Vijay’s allegations); see also
Hoggard, supra note 82 (reporting Vijay has asked for $5 million in damages).
196. See Singh, 2014 WL 641311, at *9–10 (discussing Tour placing Vijay’s
money in escrow and Manual requirements); see also supra notes 156–58 (discuss-
ing Tour placing Vijay’s money in escrow and Manual requirements).
22
Jeffrey S. Moorad Sports Law Journal, Vol. 23, Iss. 1 [2016], Art. 8
https://digitalcommons.law.villanova.edu/mslj/vol23/iss1/8
2016] BATTLING THE PGA TOUR 359
The court will apply the facts of Vijay’s situation to New York’s law
of conversion, which includes a two-prong test and an additional
comment on conversion of money.197  The first prong considers
whether Vijay had a “possessory right or interest in the property.”198
From the perspective of the gallery, Vijay has a hole in one when it
comes to his right or interest in his property, which includes the
earnings he received playing in a golf tournament.199
However, the second prong is less clear when determining
whether the Tour’s “dominion over the property or interference
with it” was “in derogation of plaintiff’s rights.”200  Although the
Tour had the legal right to control Vijay’s property, according to
the Manual, they must first provide notice of any potential violation
before placing the money in escrow.201  However, the Tour will
have an uphill battle at trial because it did not provide Vijay notice
before placing his money in escrow.202
Vijay will most likely win this second prong as well because the
Tour supposedly provided Vijay notice on February 14, 2013, but
began holding his prize money from a tournament he played from
February 7–10.203  At trial, the Tour must present evidence that it
provided notice to Vijay before the tournament on February 7th.204
Vijay will likely win this prong unless the Tour presents alternative
evidence disputing the its letters to Vijay, which reveal the Tour
began holding his earnings in escrow before they provided
notice.205
While the chances of Vijay winning the two conversion prongs
at trial looks like a routine tap in, the remaining stand-alone crite-
ria regarding conversion may be somewhat more challenging.206
197. See Singh, 2014 WL 641311, at *9 (defining New York law of conversion);
see also supra notes 152–54 and accompanying text (describing applicable legal
standard).
198. See id. (quoting Lynch v. City of New York, 965 N.Y.S.2d 441, 446 (N.Y.
App. Div. 2013)).
199. See id. at *10 (discussing Vijay’s tour prize money underlying conversion
claim).
200. See id. at *9 (quoting Lynch, 965 N.Y.S.2d at 446) (detailing second prong
of conversion analysis).
201. See id. at *9–10 (discussing Manual’s notice requirements); see also supra
note 156–57 and accompanying text (same).
202. See Singh, 2014 WL 641311, at *9 (referring to recent evidence
submissions).
203. See id. at *10 (detailing notice letters from Tour).
204. See id. (suggesting Tour’s counter arguments to Vijay’s claims).
205. See id. (finding that Vijay’s allegations established this prong in light of
initial evidence).
206. See id. at *9 (“[A]n action for conversion of money may be made out
where there is a specific, identifiable fund and an obligation to return or otherwise
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While Vijay can show the identifiable funds were his earnings, he
may have a more difficult task convincing the court that the Tour
did not “return or otherwise treat in a particular manner the spe-
cific fund in question.”207  This may be difficult because, as the
Manual requires, the Tour returned the money when it dropped
the investigation.208  Vijay will argue that the Tour did not treat the
funds in the particular manner required by the Manual because it
placed them in escrow before providing notice.209
Overall, the Tour will likely win on this criterion because lack
of notice would not play a role since the Tour treated the funds
appropriately and returned them once the investigation con-
cluded.210  Nonetheless, this criterion seems to be a freestanding
element and courts more commonly apply the two-pronged test to
conversion claims.211  As a result, Vijay has a prime opportunity to
succeed on his conversion claims at trial because he has strong ar-
guments in his favor for the two-prong test, while the Tour has a
better chance of prevailing on the stand-alone criteria.212
IV. CONCLUSION
A January 2013 Sports Illustrated article began a whirlwind
journey pitting Vijay against the Tour.213  The saga appeared to be
over when the Tour dropped its investigation of Vijay.214  Unbe-
knownst to golf fans and legal analysts, April 30, 2013 was just the
first round.215  Just over a week later, Vijay filed a lawsuit targeting
the Tour’s Anti-Doping Program.216  However, the court’s initial
treat in a particular manner the specific fund in question.” (quoting Thys v. Fortis
Sec. LLC, 903 N.Y.S.2d 368, 369 (N.Y. App. Div. 2010)); see also supra note 152 and
accompanying text (noting stand alone prong requirements).
207. See id. at *9–10 (comparing Vijay’s facts to stand alone conversion
criteria).
208. See PGA TOUR ANTI-DOPING PROGRAM MANUAL, supra note 61, sec. 2(L)
(providing requirements for returning money after investigation concludes).
209. See supra note 158 and accompanying text (reasoning Tour did not fol-
low protocol); see also Singh, 2014 WL 641311, at *10 (concluding that Vijay’s alle-
gations established he was not given proper notice under Manual).
210. See supra notes 155–56 and accompanying text (indicating Tour may win
this argument because it followed protocol after placing money in escrow).
211. See supra notes 152–53 and accompanying text (noting different conver-
sion criteria).
212. See supra notes 151–59 and accompanying text (presenting conversion
criteria to be used by court).
213. See DiMeglio, supra note 7 (reporting Vijay admitted using deer antler
spray).
214. See id. (announcing Tour dropped disciplinary action against Vijay).
215. See id. (noting date Tour dropped investigation of Vijay).
216. See id. (reporting Vijay’s lawsuit against Tour).
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ruling dismissed five of Vijay’s seven allegations, leaving only claims
of breach of covenant of good faith and fair dealing and conversion
for trial.217
Although Vijay’s lawsuit was softened through dismissal and
limited by the scope of discovery, it still has the potential to rock
the golf world.218  Vijay’s trial could drastically affect how the Tour
handles Anti-Doping Program violations by partially pulling back
the veil of secrecy that shrouds the policy.219
Ironically, over two years after Vijay filed suit against the Tour
and its Anti-Doping Program, the Tour has blatantly ignored calls
for transparency.220  Specifically, when Commissioner Tim Finchem
was asked about the desire of golf fans to know about player disci-
pline issues he said, “we don’t think the fans really want to know
about most of the stuff we would be talking about.”221  Contrary to
the Commissioner’s statement, a recent Golf Digest poll revealed
that seventy-five percent of golf fans are interested in whether a
player is disciplined by the Tour.222
Even though the Tour has adamantly resisted transparency of
the Anti-Doping Program, Singh v. PGA Tour may force the Tour to
change.223  If successful in his lawsuit Vijay could single-handedly
alter the administration of the Anti-Doping Program and, in a twist
of fate that seemed far-fetched when Vijay filed suit, alter the public
217. See supra notes 99–120 (detailing court’s partial dismissal of Vijay’s allega-
tions); see also Singh v. PGA Tour, Inc., No. 651659/2013, 2014 WL 641311, at
*14–15 (N.Y. Sup. Ct. N.Y. Cnty. Feb. 13, 2014) (granting Tour’s Motion to dismiss
as to five claims, and denying it as to remaining claims for conversion and breach
of covenant of good faith and fair dealing).
218. See Why the PGA Tour Should Fear Vijay Singh, supra note 167 (discussing
significant potential impact of Vijay’s lawsuit).
219. See Jeff Rude, Singh Hopes to Blow Lid Off PGA Tour’s Drug Policy, GOLF
WEEK (Nov. 6, 2013), http://golfweek.com/news/2013/nov/06/pga-tour-vijay-
singh-drug-policy-accusations/ (reporting goal of Vijay’s lawsuit is to reveal secrets
of Tour’s policy).
220. See Weinman, supra note 44 (noting Tour’s resistance to change even
when faced with lawsuit).
221. Id. (quoting Commissioner Finchem’s denial, in stark contrast to truth,
that fans want player discipline publicized).
222. See As a Golf Fan, Are You Interested in Whether a Player Is Disciplined by the
PGA Tour?, POLL DADDY, https://polldaddy.com/poll/8714616/?view=results&
msg=voted (last visited Mar. 8, 2016) (citing poll results revealing Commissioner is
out of touch with golf fans).
223. See Weinman, supra note 44 (affirming Tour’s resistance to
transparency).
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perception of the Tour by increasing transparency for the contro-
versial Anti-Doping Program.224
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